Ainos (NASDAQ:AIMD – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.09) EPS for the quarter, FiscalAI reports.
Ainos Stock Performance
Ainos stock opened at $1.14 on Tuesday. Ainos has a 12 month low of $0.43 and a 12 month high of $3.88. The stock’s 50 day simple moving average is $1.09 and its two-hundred day simple moving average is $1.54.
Analysts Set New Price Targets
Separately, Weiss Ratings raised Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Ainos has an average rating of “Sell”.
Get Our Latest Report on Ainos
About Ainos
Ainos, Inc. is a health technology company developing products that combine artificial intelligence with sensing and diagnostic technologies. Its work includes the AI Nose platform, designed to detect and analyze volatile organic compounds (VOCs) for potential use in health care and other applications. The company also develops VELDONA, a low-dose interferon-alpha product, and point-of-care testing solutions. Ainos focuses on advancing these offerings for human and veterinary health uses, alongside applications for VOC monitoring.
Read More
- Five stocks we like better than Ainos
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
